What was studied?
This multicenter, double-blind, placebo-controlled study enrolled 117 adults undergoing bowel resection. The key efficacy measure was the time until a standardized solid meal could be tolerated; adverse events were also monitored.
What did the researchers report?
The median time to a tolerated meal was numerically shorter with ipamorelin, but the difference was not statistically significant. The investigators found no significant differences in the key or secondary efficacy analyses.
What are the limits?
A numerical difference alone does not establish efficacy. The authors described a small proof-of-concept study with a heterogeneous surgical population. Its hospital setting and study formulation do not support personal-use recommendations or claims about catalog materials.
Original editorial summary by Sulan Peptide. Based on the source abstract; consult the full paper for methods, analyses, funding and disclosures.